Skip to content
Esta página está disponible en españolCambiar →

Great investors · Andreas Halvorsen · Q4 2025

What Andreas Halvorsen bought and sold in Q4 2025

Viking Global 13F portfolio as of Dec 31, 2025: 76 positions worth $37.7 bn. Largest: MSFT, PNC, TSM, V. Filed with the SEC on Feb 17, 2026.

The 13F is filed by Viking Global, not by Andreas Halvorsen personally: these are the whole firm's positions. A “position” is a distinct security in the filing (by CUSIP); share classes of the same company are shown added together.

Buys in Q4 2025

Sells in Q4 2025

44 companies with material moves, out of 88 positions with a change. Only moves of 0.5 points of the portfolio or more are listed, measured as “traded weight” (what was bought or sold, excluding price effects). Smaller changes exist and are not listed: a position may have gone up or down without appearing above.

The full 13F, line by line

Viking Global's Q4 2025 13F lists 76 lines of US-listed securities worth $37.7 bn; the largest is MSFT at 4.13% of the portfolio. It was accepted by the SEC on Feb 17, 2026 at 4:59 PM ET.

Against the previous quarter, it opened 21 positions (GOOGL, ICE, AMZN and DKS and 17 more), closed 23 (BLK, PM, META and NKE and 19 more), added to 17 (CHWY, V, MSFT and TSM and 13 more) and trimmed 28 (COF, JPM, GM and SCHW and 24 more). 10 lines show the same number of shares.

#CompanySharesValueWeightChange in shares
1Microsoft MSFT3.2 M$1.6 bn4.13%+32%
2PNC Financial Services Group PNC7.3 M$1.5 bn4.04%−8.4%
3Taiwan Semiconductor Manufacturing TSM4.9 M$1.5 bn3.96%+25%
4Visa V4.0 M$1.4 bn3.71%+38%
5Charles Schwab SCHW13.9 M$1.4 bn3.68%−16%
6Walt Disney DIS11.2 M$1.3 bn3.38%+7.1%
7Air Products and Chemicals APD4.8 M$1.2 bn3.14%+30%
8McDONALD’S MCD3.6 M$1.1 bn2.94%+7.2%
9BridgeBio Pharma BBIO14.4 M$1.1 bn2.92%−9.9%
10Fortive FTV19.2 M$1.1 bn2.82%−6.1%
11Sherwin-williams SHW3.2 M$1.0 bn2.73%+10%
12Boeing BA4.0 M$858M2.28%+31%
13Alphabet GOOGL2.7 M$835M2.21%new
14Advanced Micro Devices AMD3.7 M$801M2.13%−11%
15Intercontinental Exchange ICE4.8 M$778M2.06%new
16Tesla TSLA1.7 M$764M2.03%+5.6%
17T-mobile US TMUS3.8 M$762M2.02%+15%
18Amazon.com AMZN3.1 M$722M1.92%new
19Capital One Financial COF3.0 M$716M1.90%−60%
20Johnson Controls International JCI5.9 M$709M1.88%−13%
21Draftkings DKNG19.1 M$659M1.75%+27%
22JPMorgan Chase JPM1.9 M$614M1.63%−62%
23Ross Stores ROST3.2 M$571M1.51%+57%
24General Motors GM6.8 M$553M1.47%−48%
25Mid-america Apartment Communities MAA3.9 M$539M1.43%+47%
26Camden Property Trust CPT4.8 M$524M1.39%+24%
27DICK'S Sporting Goods DKS2.6 M$509M1.35%new
28Celestica CLS1.7 M$502M1.33%−1.4%
29CSX CSX13.8 M$501M1.33%−13%
30Adaptive Biotechnologies ADPT30.0 M$487M1.29%no change
31Sea SE3.7 M$468M1.24%+21%
32HCA Healthcare HCA999,180$466M1.24%−28%
33Thermo Fisher Scientific TMO793,187$460M1.22%new
34Regal Rexnord RRX3.2 M$452M1.20%+3.2%
35Carvana CVNA1.1 M$448M1.19%−49%
36Chewy CHWY13.5 M$447M1.19%+147%
37APi Group APG11.5 M$441M1.17%−6.2%
38Stellantis STLA39.1 M$434M1.15%new
39Carnival CCL14.1 M$429M1.14%new
40UBS Group UBS9.1 M$426M1.13%−30%
41UnitedHealth Group UNH1.2 M$395M1.05%new
42BioMarin Pharmaceutical BMRN6.0 M$359M0.95%−27%
43Saia SAIA1.1 M$355M0.94%−21%
44TIC Solutions TIC34.4 M$347M0.92%no change
45Chubb CB1.0 M$316M0.84%new
46Progressive PGR1.3 M$303M0.80%new
47Lennox International LII621,311$302M0.80%new
48Tradeweb Markets TW2.8 M$298M0.79%new
49Medline MDLN7.0 M$292M0.78%new
50Aon AON783,650$277M0.73%−45%
51Arthur J. Gallagher AJG1.0 M$269M0.72%new
52Bank of America BAC4.5 M$247M0.66%−61%
53Boston Scientific BSX2.5 M$239M0.64%−5%
54Digital Realty Trust DLR1.5 M$233M0.62%new
55Lowe's LOW912,040$220M0.58%new
56Figma FIG5.8 M$215M0.57%new
57Itau Unibanco Holding ITUB28.4 M$203M0.54%new
58Amer Sports AS4.8 M$180M0.48%−24%
59Ralliant RAL3.2 M$161M0.43%−38%
60RIOT Platforms RIOT12.4 M$157M0.42%new
61NewAmsterdam Pharma NAMS4.2 M$147M0.39%−35%
62Roivant Sciences ROIV6.4 M$140M0.37%−73%
63IQVIA Holdings IQV619,236$140M0.37%new
64Sionna Therapeutics SION3.2 M$131M0.35%no change
65Inhibrx Biosciences INBX1.4 M$114M0.30%−20%
66Pharvaris PHVS3.7 M$101M0.27%no change
67CoStar Group CSGP1.4 M$97.0M0.26%−22%
68West Pharmaceutical Services WST295,028$81.2M0.22%new
69Oruka Therapeutics ORKA2.7 M$80.8M0.21%no change
70Standard Biotools LAB58.7 M$75.1M0.20%no change
71Masimo MASI514,340$66.9M0.18%−52%
72ORIC Pharmaceuticals ORIC6.6 M$53.8M0.14%no change
73Trevi Therapeutics TRVI3.2 M$40.0M0.11%−38%
74Ginkgo Bioworks Holdings DNA3.6 M$29.7M0.08%no change
75Pepgen PEPG3.5 M$22.7M0.06%no change
76Rallybio 4.2 M$2.9M0.01%no change

Positions it closed (23)

One row per line of the filing (by CUSIP): share classes of the same company are listed separately here. “Change in shares” compares the count with the previous quarter, split-adjusted; the value is the one reported in the 13F at quarter end, not today's price.

Original documents: Viking Global's 13F filings on EDGAR (SEC) ↗

Full 13F of Viking Global: sectors and history →

Follow Andreas Halvorsen and see their Q3 2026 13F once it is filed

Free. We email you (if you turn it on) and in Following you see what each manager you follow bought and sold.

Follow Andreas Halvorsen

Source: 13F filings with the SEC. A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions. Not investment advice.

Follow Andreas Halvorsen for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow Andreas Halvorsen